Registration Fee: Free! Please register using the link above/below.
Workshop Summary
This workshop brings together clinical researchers, academic scientists, and industry partners to explore key challenges in understanding respiratory aerosols and their behaviour in the human lung. Applications range from inhaled drug delivery and the transmission of infectious diseases to the health impacts of air pollution. Through focused talks and collaborative discussion, we aim to identify the major unknowns in mathematically and computationally modelling aerosol transport, deposition, and clearance in respiratory pathways. The workshop will highlight how existing device technologies and measurement capabilities can inform and constrain modelling efforts, and it will lay the groundwork for future interdisciplinary research directions that advance both scientific understanding and practical healthcare outcomes.
Objectives
Knowledge exchange between groups working on modelling the behaviour of aerosols in the context of human health.
Identification of key gaps in current modelling capabilities and key opportunities for the use of computational modelling of aerosol for health applications.
Foster new multi-disciplinary collaborations between academia and industry to address these gaps and harness these opportunities.
Draft Agenda
10:00: Registration, Refreshments & Networking
10:30–10:50 — Welcome & Introduction
Background and Objectives of the workshop
10:50–11:20: Introductions (Flash talks – 1 slide / 1 min)
11:20–11:30: Coffee break
11:30–12:30 — Session 1: Perspectives on Respiratory Aerosols
Talk 1: Clinical challenges in understanding aerosol behaviour in the lungs
Talk 2: Characterising the role of respiratory aerosols in disease transmission
Talk 3: The evolution of pollutant mixtures in the atmosphere
Panel-style Q&A
12:30–13:00 — Lunch & Informal Networking
13:00–14:00 — Session 2: Industrial Aerosol Biotechnology
Talk 4 From lab to lung: scalable manufacturing and formulation technologies for industrial translation of next-generation aerosol bacteriophage therapies
Talk 5: Aerosol formulation and simulation technologies from industry
Talk 6: Practical and theoretical challenges in delivering inhaled therapies
Panel-style Q&A
14:00–14:30 — Session 3: Key Challenges and Unknowns
Roundtable discussion on modelling limitations
Identifying critical gaps in data, measurement, and validation
Identifying key application areas where existing technologies could be used
14:30–15:00 — Focussed discussions
Forming breakout groups based on identified applications and collaborations
15:00–15:30 — Closing Discussion & Next Steps
Summary of breakout outcomes
Identifying opportunities for collaboration and follow-up
15:30–16:00 — Drinks & Departures